Scilex Holding Co. (SCLX)

$19.40 -0.54 (-2.71%)
Market Cap 142.23M
Revenue (ttm) 56.59M
Net Income (ttm) -72.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -128.66%
Debt to Equity Ratio -0.25
Volume 62,500
Avg Vol 192,336
Day's Range N/A - N/A
Shares Out 7.59M
Stochastic %K 12%
Beta 1.32
Analysts Hold
Price Target $367.13

Company Profile

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 650 516 4310
Address:
960 San Antonio Road, Palo Alto, United States
TheToaster
TheToaster Dec. 5 at 12:46 AM
$SCLX $SRNE Hahahaha The only surname you're ever gonna replace DJ w is Ms. Miss or Mrs. 😆
0 · Reply
JR214
JR214 Dec. 4 at 5:04 PM
$SCLX Been busy, anyone received any information on when and how to go about setting up Datavault ai wallet and opting in to receive Dreamsbowl meme coins? When…? Etc.
1 · Reply
JR214
JR214 Dec. 4 at 4:51 PM
$SCLX Ready to fly!
0 · Reply
BioCEOsSukk
BioCEOsSukk Dec. 4 at 3:21 PM
$SCLX be vewwy, vewwy quiet. We're selling all or some more of Semdexa... #NFA #Opinion
0 · Reply
Skunky
Skunky Dec. 4 at 1:55 PM
$DVLT $SCLX Dude said bears are “retards,” then confidently claimed DVLT had $591M in BTC. SEC filing says ~$150M. Showed him the math → he argued → then blocked me. Wild how facts trigger some folks.
1 · Reply
LeviBetta
LeviBetta Dec. 4 at 2:59 AM
$SCLX $SRNE 5yrs ago the SEC filings and press releases impressed me. Now, I imagine Ji opening a garage chest freezer and moving a chuck roast to pull out a Ziploc bag containing 2 test tubes and labeled "GMAB Library".
3 · Reply
Cats_and_Roses
Cats_and_Roses Dec. 4 at 2:06 AM
$SCLX are we finally going to see in 2025 the juicy Christmas bonus that Ji promised us in 2020? 🤣😅
2 · Reply
DjLaFlecha
DjLaFlecha Dec. 3 at 11:50 PM
$SCLX $SCLX Toaster after learning that a Dj was all along smarter than him 😄
2 · Reply
Oldslapnuts
Oldslapnuts Dec. 3 at 7:00 PM
$DVLT $SCLX Have a Partnership, not a one sided Relationship. Their success is dependent on one another. Big things ahead for Both.
1 · Reply
stillneedtolearn
stillneedtolearn Dec. 3 at 5:12 PM
$DVLT so if $SCLX holds most of are stock shouldn't we buy that too? just asking cuz i just got a few of em pt is crazy ill just put them away got in at 19$
1 · Reply
Latest News on SCLX
Scilex Holding Company Announces Closing of Previously Announced Second Tranche Investment in Datavault AI Inc., Completing Its Two-Tranche Equity Financing in Datavault AI Inc.

Nov 26, 2025, 6:00 AM EST - 9 days ago

Scilex Holding Company Announces Closing of Previously Announced Second Tranche Investment in Datavault AI Inc., Completing Its Two-Tranche Equity Financing in Datavault AI Inc.

Scilex Holding Company Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds

Nov 25, 2025, 2:37 PM EST - 9 days ago

Scilex Holding Company Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds

Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds

Nov 24, 2025, 6:00 AM EST - 11 days ago

Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds

Scilex Holding Company Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin by Datavault AI Inc.

Nov 21, 2025, 3:59 PM EST - 13 days ago

Scilex Holding Company Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin by Datavault AI Inc.

Scilex Holding Company Announces that the Board of Directors of Datavault AI Inc. Has Approved the Distribution of a Dream Bowl 2026 Meme Coin to All Eligible Scilex and Datavault AI Stockholders of Record and Set a Record Date of November 25, 2025

Nov 11, 2025, 9:30 AM EST - 23 days ago

Scilex Holding Company Announces that the Board of Directors of Datavault AI Inc. Has Approved the Distribution of a Dream Bowl 2026 Meme Coin to All Eligible Scilex and Datavault AI Stockholders of Record and Set a Record Date of November 25, 2025

Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug information from Datavault AI

Nov 4, 2025, 6:00 AM EST - 4 weeks ago

Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug information from Datavault AI

Scilex Holding Company Announces the Sponsorship of Dream Bowl 2026 and Set a Record Date of November 14, 2025 for Its Shareholders to Receive Dream Bowl 2026 Meme Coin Distributed by DataVault AI

Nov 3, 2025, 9:53 AM EST - 4 weeks ago

Scilex Holding Company Announces the Sponsorship of Dream Bowl 2026 and Set a Record Date of November 14, 2025 for Its Shareholders to Receive Dream Bowl 2026 Meme Coin Distributed by DataVault AI

Datavault AI Announces Record Date of Nov. 14, 2025, for Dream Bowl Draft Meme Coin Distribution to All Eligible Scilex and Datavault AI Shareholders

Nov 3, 2025, 8:45 AM EST - 4 weeks ago

Datavault AI Announces Record Date of Nov. 14, 2025, for Dream Bowl Draft Meme Coin Distribution to All Eligible Scilex and Datavault AI Shareholders

DVLT

Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase

Oct 1, 2025, 9:00 AM EDT - 2 months ago

Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase

Datavault AI Announces Closing of Initial Tranche Investment from Scilex Holding Company

Sep 26, 2025, 4:12 PM EDT - 2 months ago

Datavault AI Announces Closing of Initial Tranche Investment from Scilex Holding Company

DVLT

Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI

Sep 26, 2025, 3:57 PM EDT - 2 months ago

Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI

Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI

Sep 25, 2025, 3:45 PM EDT - 2 months ago

Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bitcoin

Sep 25, 2025, 6:00 AM EDT - 2 months ago

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bitcoin

Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management

Sep 24, 2025, 10:11 AM EDT - 2 months ago

Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) Announces Signing of a Securities Purchase Agreement with an Institutional Investor for the Purchase of $100 Million of shares of Semnur Common Stock in Exchange for $100 Million in Bitcoin

Sep 23, 2025, 11:12 AM EDT - 2 months ago

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) Announces Signing of a Securities Purchase Agreement with an Institutional Investor for the Purchase of $100 Million of shares of Semnur Common Stock in Exchange for $100 Million in Bitcoin

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

Sep 23, 2025, 10:00 AM EDT - 2 months ago

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 2025

Sep 23, 2025, 6:00 AM EDT - 2 months ago

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 2025

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination

Sep 22, 2025, 3:49 PM EDT - 2 months ago

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali's Shareholders of the Previously Announced Business Combination

Sep 4, 2025, 9:00 AM EDT - 3 months ago

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali's Shareholders of the Previously Announced Business Combination

Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.00 per share and Jaisim Shah, Scilex's CEO and President, Will be Dedicated to Semnur on a Full Time Basis to Rapidly Advance SP-102 to Regulatory Approval and Commercialization for the Treatment of Lumbosacral Radicular Pain (LRP)/Sciatica

Aug 21, 2025, 6:00 AM EDT - 3 months ago

Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.00 per share and Jaisim Shah, Scilex's CEO and President, Will be Dedicated to Semnur on a Full Time Basis to Rapidly Advance SP-102 to Regulatory Approval and Commercialization for the Treatment of Lumbosacral Radicular Pain (LRP)/Sciatica

Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex

Aug 13, 2025, 6:00 AM EDT - 4 months ago

Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a future date to be determined by the Board

Jun 23, 2025, 4:50 PM EDT - 5 months ago

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a future date to be determined by the Board

Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal

Jun 5, 2025, 12:05 PM EDT - 6 months ago

Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal

Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL

May 16, 2025, 9:00 AM EDT - 7 months ago

Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL

Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL.

May 1, 2025, 9:00 AM EDT - 7 months ago

Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL.

Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule

Apr 30, 2025, 1:46 PM EDT - 7 months ago

Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 2025 to May 2, 2025

Apr 22, 2025, 9:00 AM EDT - 8 months ago

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 2025 to May 2, 2025

Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

Apr 16, 2025, 2:12 PM EDT - 8 months ago

Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada's Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®'s Acute Treatment of Migraine With or Without Aura in Canada

Apr 15, 2025, 9:00 AM EDT - 8 months ago

Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada's Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®'s Acute Treatment of Migraine With or Without Aura in Canada

Scilex Holding Company Announces 1-for-35 Reverse Stock Split

Apr 11, 2025, 9:00 AM EDT - 8 months ago

Scilex Holding Company Announces 1-for-35 Reverse Stock Split

Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva

Mar 26, 2025, 8:24 PM EDT - 9 months ago

Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, 2025 to April 11, 2025

Mar 10, 2025, 9:00 AM EDT - 9 months ago

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, 2025 to April 11, 2025

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

Jan 31, 2025, 9:00 AM EST - 10 months ago

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)

Jan 21, 2025, 11:49 AM EST - 11 months ago

Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)

Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

Jan 21, 2025, 9:46 AM EST - 11 months ago

Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC

Jan 21, 2025, 9:00 AM EST - 11 months ago

Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC

Scilex Holding Company Announces Filing of its Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2024

Jan 21, 2025, 6:00 AM EST - 11 months ago

Scilex Holding Company Announces Filing of its Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2024

Scilex Holding Company Amends its License Agreement with Romeg Therapeutics, LLC, For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares in Adults

Jan 16, 2025, 3:38 PM EST - 11 months ago

Scilex Holding Company Amends its License Agreement with Romeg Therapeutics, LLC, For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares in Adults

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from November 7, 2024 to January 28, 2025

Dec 30, 2024, 9:00 AM EST - 1 year ago

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from November 7, 2024 to January 28, 2025

Scilex Holding Company Announces Closing of $17 Million Registered Direct Offering

Dec 13, 2024, 12:23 PM EST - 1 year ago

Scilex Holding Company Announces Closing of $17 Million Registered Direct Offering

Scilex Holding Company Announces $17 Million Registered Direct Offering

Dec 12, 2024, 8:21 AM EST - 1 year ago

Scilex Holding Company Announces $17 Million Registered Direct Offering

Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer's Disease (AD) Currently Enrolling with U.S. Patient Cohort to be Added in 2025

Dec 11, 2024, 12:49 PM EST - 1 year ago

Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer's Disease (AD) Currently Enrolling with U.S. Patient Cohort to be Added in 2025

Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Positive Results from the Recently Completed Phase 1 Trials Conducted by NeuroBiogen for KDS2010, a Novel Oral Tablet Recently Synthesized Potent, Selective, and Reversible Monoamine Oxidase B inhibitor

Dec 11, 2024, 7:30 AM EST - 1 year ago

Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Positive Results from the Recently Completed Phase 1 Trials Conducted by NeuroBiogen for KDS2010, a Novel Oral Tablet Recently Synthesized Potent, Selective, and Reversible Monoamine Oxidase B inhibitor

Scilex Holding Company Announces Receipt of Notice from Nasdaq

Nov 22, 2024, 6:00 AM EST - 1 year ago

Scilex Holding Company Announces Receipt of Notice from Nasdaq

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and Denali

Nov 6, 2024, 12:24 PM EST - 1 year ago

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and Denali

Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, SP-103 (Lidocaine Topical System) 5.4%, a Next-Generation, Triple-Strength Formulation of ZTlido, for the Treatment of Chronic Neck Pain Associated with Muscle Spasms

Oct 30, 2024, 6:00 AM EDT - 1 year ago

Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, SP-103 (Lidocaine Topical System) 5.4%, a Next-Generation, Triple-Strength Formulation of ZTlido, for the Treatment of Chronic Neck Pain Associated with Muscle Spasms

Scilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock

Oct 29, 2024, 6:00 AM EDT - 1 year ago

Scilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary

Oct 28, 2024, 6:00 AM EDT - 1 year ago

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 Billion

Oct 16, 2024, 4:00 AM EDT - 1 year ago

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 Billion

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024

Oct 8, 2024, 1:58 PM EDT - 1 year ago

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024

TheToaster
TheToaster Dec. 5 at 12:46 AM
$SCLX $SRNE Hahahaha The only surname you're ever gonna replace DJ w is Ms. Miss or Mrs. 😆
0 · Reply
JR214
JR214 Dec. 4 at 5:04 PM
$SCLX Been busy, anyone received any information on when and how to go about setting up Datavault ai wallet and opting in to receive Dreamsbowl meme coins? When…? Etc.
1 · Reply
JR214
JR214 Dec. 4 at 4:51 PM
$SCLX Ready to fly!
0 · Reply
BioCEOsSukk
BioCEOsSukk Dec. 4 at 3:21 PM
$SCLX be vewwy, vewwy quiet. We're selling all or some more of Semdexa... #NFA #Opinion
0 · Reply
Skunky
Skunky Dec. 4 at 1:55 PM
$DVLT $SCLX Dude said bears are “retards,” then confidently claimed DVLT had $591M in BTC. SEC filing says ~$150M. Showed him the math → he argued → then blocked me. Wild how facts trigger some folks.
1 · Reply
LeviBetta
LeviBetta Dec. 4 at 2:59 AM
$SCLX $SRNE 5yrs ago the SEC filings and press releases impressed me. Now, I imagine Ji opening a garage chest freezer and moving a chuck roast to pull out a Ziploc bag containing 2 test tubes and labeled "GMAB Library".
3 · Reply
Cats_and_Roses
Cats_and_Roses Dec. 4 at 2:06 AM
$SCLX are we finally going to see in 2025 the juicy Christmas bonus that Ji promised us in 2020? 🤣😅
2 · Reply
DjLaFlecha
DjLaFlecha Dec. 3 at 11:50 PM
$SCLX $SCLX Toaster after learning that a Dj was all along smarter than him 😄
2 · Reply
Oldslapnuts
Oldslapnuts Dec. 3 at 7:00 PM
$DVLT $SCLX Have a Partnership, not a one sided Relationship. Their success is dependent on one another. Big things ahead for Both.
1 · Reply
stillneedtolearn
stillneedtolearn Dec. 3 at 5:12 PM
$DVLT so if $SCLX holds most of are stock shouldn't we buy that too? just asking cuz i just got a few of em pt is crazy ill just put them away got in at 19$
1 · Reply
TheToaster
TheToaster Dec. 3 at 4:37 PM
$SCLX you don't need a Toaster because YOU DONT HAVE ANY BREAD!!! HAHAHAHAHAHAHAHAHAHAHA. You gave it all to Ji and shorts.....now get a job ao you can buy some food and maybe even get your own internet instead of using the library whilst whining about the evils of socialism lol 😆
1 · Reply
Sacsofcash
Sacsofcash Dec. 2 at 7:30 PM
$SCLX something is definitely up.
2 · Reply
GladysFoster
GladysFoster Dec. 2 at 5:56 PM
$SCLX so Scilex’s stake represents roughly **~ 93 %** of the Datavault AI company’s outstanding shares.... So really they own it???
1 · Reply
BioCEOsSukk
BioCEOsSukk Dec. 2 at 4:51 PM
$SRNE $DVLT $SCLX IMO something is brewing here and all 3 companies might be connected whether directly or indirectly...
0 · Reply
Ichigodoran
Ichigodoran Dec. 2 at 4:17 PM
Building Momentum and a Fortified Balance Sheet The Triton deal is not an anomaly but the latest milestone in a consistent pattern of strategic execution. Since its transformation, Datavault AI has been methodically securing partnerships across diverse, high-value industries, including multi-million dollar licensing agreements with Scilex Holding (NASDAQ: $SCLX) (biotech) and Nature's Miracle (NASDAQ: $NMHI) (carbon credits). This trend demonstrates that the company's platform is versatile and in demand. https://finance.yahoo.com/news/datavault-ai-just-raised-guidance-000600613.html
0 · Reply
Rookie69
Rookie69 Dec. 2 at 1:28 PM
$DVLT $SCLX This takes the cake, Ji is a world class bullshit artist LOL This tops the test to reopen society, stem cells 10/10 rose from the dead , worlds largest antibody library etc etc
2 · Reply
JustAGoodOleBoy22
JustAGoodOleBoy22 Dec. 2 at 2:56 AM
$SCLX 6 yrs later....cant make this shit up!!! Glta
1 · Reply
Down_Again
Down_Again Dec. 2 at 2:18 AM
$DVLT deal with $SCLX: Datavault will earn sales milestone payments of up to an aggregate of $2.55 BILLION upon the achievement of certain applicable sales milestones. SCLX is looking to tokenize over $2 trillion worth of pharmaceutical & diagnostic sales, as well as, enable companies to raise funds at lower cost with DVLT tech. There's more to the story than $115 million in Bitcoin. Imagine what IBM can achieve with its portfolio of assets combined with DVLT tech. https://finance.yahoo.com/news/scilex-holding-company-announces-worldwide-110000063.html
2 · Reply
chicken_stock1
chicken_stock1 Dec. 2 at 12:21 AM
$SCLX Ji is in it for....... Ji. .... BTW, here is the MRI ***
3 · Reply
KimCoyneFactoryPR
KimCoyneFactoryPR Dec. 1 at 11:58 PM
$SCLX fun day today. Nice to know @Sacsofcash went further into debt.
1 · Reply
Awaywithshorts
Awaywithshorts Dec. 1 at 11:36 PM
$SCLX It’s December. Game time
0 · Reply
jonofdubln
jonofdubln Dec. 1 at 11:15 PM
$SCLX Sacs says the shorts are smelling their own asses. Down $1.28 per share now. I think they are smelling your money, just like they have since the dividend was released at a 35-1 RS adjusted $350. How long will it take to break even for us faithful????
0 · Reply